EYRAplex: Human In vitro cytokine release (8‑plex)
EYRAplex: Human In vitro cytokine release (8‑plex)
$1,800
Components
| Capture mAb | Capture bead mix: Human In vitro cytokine release (8-plex) | 
| Detection mAb | Detection mAb mix: Human In vitro cytokine release (8-plex) | 
| Standard | Standard mix A: EYRAplex, human | 
| Fluorophore conjugate | Streptavidin-PE | 
| Buffers/Solutions | Assay diluent: EYRAplex | 
| Streptavidin-PE diluent | |
| Wash buffer concentrate | |
| Also provided | 96-well plate (black) | 
| Adhesive plate covers | |
| Black plate lid | 
In stock
Delivery 4-9 business days
Shipping $0
Performance
| Analyte | LOD (pg/ml) | LLOQ (pg/ml) | ULOQ (pg/ml) | Intra-assay CV(%) | Inter-assay CV(%) | 
|---|---|---|---|---|---|
| GM-CSF | 0.1 | 0.7 | 540 | 4 | 7 | 
| IFN-γ | 0.1 | 0.8 | 610 | 4 | 7 | 
| IL-2 | 0.2 | 6.1 | 1470 | 4 | 6 | 
| IL-4 | 0.2 | 3.3 | 2400 | 5 | 7 | 
| IL-6 | 0.1 | 3.3 | 2430 | 4 | 5 | 
| IL-8 (CXCL8) | 0.53 | 6.0 | 4340 | 5 | 7 | 
| IL-10 | 0.1 | 1.2 | 840 | 3 | 6 | 
| TNF-α | 0.2 | 17.5 | 1413 | 3 | 6 | 
Average recovery (%) in
| Analyte | Heparin plasma | Citrate plasma | EDTA plasma | Serum | 
|---|---|---|---|---|
| GM-CSF | 79 | 89 | 77 | 90 | 
| IFN-γ | 74 | 77 | 66 | 84 | 
| IL-2 | 91 | 92 | 94 | 74 | 
| IL-4 | 82 | 98 | 93 | * | 
| IL-6 | 83 | 92 | 86 | 88 | 
| IL-8 (CXCL8) | 90 | 105 | 94 | 111 | 
| IL-10 | 76 | 76 | 83 | 75 | 
| TNF-α | 64 | 81 | 81 | 62 | 
Average recovery (%) in
| Analyte | RA plasma | 
|---|---|
| GM-CSF | 79 | 
| IFN-γ | 79 | 
| IL-2 | 102 | 
| IL-4 | 96 | 
| IL-6 | 99 | 
| IL-8 (CXCL8) | 97 | 
| IL-10 | 91 | 
| TNF-α | 100 | 
Documents
Publications (0)
Analyte information
GM-CSF
| Analyte description | Granulocyte macrophage-colony stimulating factor (GM-CSF) can be secreted by T cells, macrophages, endothelial cells, and fibroblasts. GM-CSF stimulates the survival and functional activities of myeloid, that is, monocytes, macrophages, DCs, neutrophils, and eosinophils. It also stimulates the differentiation and proliferation of hematological progenitors. | 
| Alternative names | Granulocyte macrophage-colony stimulating factor, GM-CSF, CSF2 | 
| Cell type | T cell | 
IFN-γ
| Analyte description | Interferon-γ (IFN-γ) is the only type II interferon. This proinflammatory cytokine is secreted by activated T cells and NK cells. It activates macrophages and endothelial cells and regulates immune responses by affecting APCs, T cells, and B cells. Production of IFN-γ by helper T cells and cytotoxic T cells is a hallmark of the Th1-type phenotype. Thus, high-level production of IFN-γ is typically associated with effective host defense against intracellular pathogens. | 
| Alternative names | Interferon-γ, Interferon-gamma, IFN-γ, IFN-gamma, IFN-g, IFNg | 
| Cell type | T cell, Tc, Th1, NK cell | 
IL-2
| Analyte description | Interleukin 2 (IL-2) is predominantly produced by activated T cells. IL-2 promotes the proliferation, differentiation, and survival of antigen-activated T cells and NK cells. After antigen stimulation, the cytokine also promotes the differentiation of T cells into effector and memory T cells. Therefore IL-2 plays an important role in the body's response to infection. IL-2 is also key to tolerance, as it promotes the differentiation of certain immature T cells into regulatory T cells in the thymus, ultimately preventing autoimmune diseases. | 
| Alternative names | Interleukin-2, Interleukin 2, IL-2, IL2, T cell growth factor | 
| Cell type | T cell, Th1, Th2, Th17, Tfh | 
IL-4
| Analyte description | Interleukin 4 (IL-4) is produced primarily by Th2 cells, mast cells, eosinophils, and basophils. IL-4 was first identified to costimulate B cell growth; the cytokine is essential for B cell secretion of IgE and augments the production of IgG1 in vivo. In addition to regulating B cell growth and immunoglobulin secretion, IL-4 also affects T cells. In vitro, IL-4 promotes T cell growth and can induce cytolytic T cell activity. IL-4 also induces the differentiation of naive CD4 T cells into Th2 cells, which are characterized by their capacity to secrete the cytokines IL-4, IL-5, and IL-10 upon activation, while simultaneously inhibiting the generation of Th1 cells. | 
| Alternative names | Interleukin 4, IL-4, IL4, BCGF-1, BSF-1 | 
| Cell type | T cell, Th2, Treg | 
IL-6
| Analyte description | Interleukin 6 (IL-6) is a pleiotropic cytokine produced by many different cell types and plays a role in a wide range of functions, such as immune responses, acute-phase reactions, and hematopoiesis. Among other things, it augments antibody production from activated B cells in vitro. | 
| Alternative names | Interleukin 6, IL-6, IL6, IFB-B502, BSF-2, BCDF | 
| Cell type | B cell, Monocyte/MΦ, mDC | 
IL-8 (CXCL8)
| Analyte description | Interleukin 8 (IL-8) is a proinflammatory cytokine produced by different types of cells, including monocytes, macrophages, and endothelial cells. Inflammatory stimuli, such as LPS, strongly induce IL-8 production by monocytes. | 
| Alternative names | Interleukin-8, IL-8, IL8, CXCL8 | 
| Cell type | T cell, Treg, Tfh, Monocyte/MΦ, mDC | 
IL-10
| Analyte description | Interleukin 10 (IL-10) is a pleiotropic cytokine produced by activated T cells and monocytes. It can modulate the functions of immune responses in both a stimulatory and an inhibitory way. IL-10 is thereby involved in the regulation of immune reactions and inflammatory responses. | 
| Alternative names | Interleukin-10, IL-10, IL10 | 
| Cell type | T cell, Treg, Monocyte/MΦ, mDC | 
TNF-α
| Analyte description | Tumor necrosis factor (TNF), also known as TNF-α, is produced by many different cell types, e.g., monocytes, macrophages, T cells, and B cells. Among the many effects of TNF-α are protection against bacterial infection, cell growth modulation, immune system regulation, and involvement in septic shock. | 
| Alternative names | Tumor necrosis factor-α, TNF-α, TNF-alpha, TNF-a, TNFa, Tumor necrosis factor-alpha, TNF | 
| Cell type | T cell, Tc, Th1, Th2, Th17, Tfh, Monocyte/MΦ | 
